115 studies found for:    "Gout"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout
Conditions: Gout;   Gout Acute
Interventions: Drug: Allopurinol;   Drug: Placebo
2 Completed Long Term Study of Canakinumab (ACZ885) in Patients With Gout
Condition: Gout
Intervention: Drug: Canakinumab
3 Completed
Has Results
Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
Condition: Gout
Intervention: Biological: Pegloticase
4 Completed
Has Results
Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout
Condition: Gout
Intervention: Biological: pegloticase
5 Withdrawn Allopurinol in Acute Gout
Condition: Gout
Intervention: Drug: allopurinol
6 Completed Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
Condition: Gout
Intervention:
7 Completed Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
8 Completed
Has Results
Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy
Condition: Gout
Interventions: Drug: Canakinumab 25 mg;   Drug: Canakinumab 50 mg;   Drug: Canakinumab 100 mg;   Drug: Canakinumab 200 mg;   Drug: Canakinumab 300 mg;   Drug: Canakinumab repeated every 4 week (q4wk);   Drug: Colchicine;   Drug: Allopurinol;   Drug: Placebo Matching Canakinumab;   Drug: Placebo Matching Colchicine
9 Completed Safety and Efficacy of Oral Febuxostat in Subjects With Gout
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol
10 Completed PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)
Condition: Gout
Interventions: Drug: placebo;   Drug: rilonacept
11 Active, not recruiting Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
Condition: Recurrent or Tophaceous Gout
Interventions: Other: Control;   Other: Gout Disease Management Program
12 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
13 Enrolling by invitation Lesinurad and Febuxostat Combination Extension Study in Gout
Condition: Gout
Intervention: Drug: lesinurad
14 Completed Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
Condition: Gout
Interventions: Drug: placebo;   Drug: BCX4208
15 Completed Does Allopurinol Prolong a Treated, Acute Gout Flare?
Condition: Gout
Interventions: Drug: allopurinol;   Drug: Placebo (sugar pill)
16 Completed A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
Condition: Gout
Intervention: Drug: Puricase
17 Completed Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: Allopurinol;   Drug: BCX4208
18 Completed Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
Conditions: Hyperuricemia;   Gout
Interventions: Drug: Arhalofenate;   Drug: Febuxostat
19 Completed Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life
Condition: Gout
Intervention:
20 Recruiting Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
Condition: Gout
Interventions: Drug: PF-06743649;   Other: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years